Efficacy and patient satisfaction in bowel cleansing protocols using polyethylene glycol-ascorbic acid (PEG) and picolyte

A prospective, randomized, controlled clinical trial for efficacy and drug tolerability using 2L polyethylene glycol-Ascorbic acid, 1L polyethylene glycol-Ascorbic acid, and picolyte with bisacodyl in patients undergoing colonoscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0004218

Enrollment

330

Registered

2019-08-20

Start date

2018-08-14

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Group A. 2 L PEG-Ascorbic acid - Using COOLPREP, total 2L, in split dose - 1L COOLPREP with 500cc of water at 9 pm before colonoscopy, another 1L COOLPREP with 500cc of water 5 hours prior t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients 18 to 74 years of age who had indications for colonoscopy.

Exclusion criteria

Exclusion criteria: Patients with impared renal (serum creatinine >= 2.0 mg/dL), hepatic (ALT >= 80 IU/L) History of gastrointestinal obstruction, ileus, severe heart failure, uncontrolled hypertension (systolic blood pressure >= 170 mmHg, diastolic blood pressure >= 100 mmHg), or any prior bowel resection.

Design outcomes

Primary

Measure	Time frame
Cleanliness of bowel cleansing	—

Secondary

Measure	Time frame
Patient satisfaction	—

Countries

Korea, Republic of

Contacts

Public ContactSang Hoon Kim

Korea University Anam Hospital

spring0107@naver.com+82-2-920-6555

Outcome results